Clinical trial

A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastases

NCT00757757

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2008-09-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2008-09-01Date precision: month

Registry last updated2020-12-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Bone Metastasesunresolved

Interventions

MCS110DRUG

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

San AntonioTexas, United States1 Las VegasNevada, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00757757 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.